1. Home /
  2. Respiratory Health /
  3. Products /
  4. Otrivine /
  5. Product range /
  6. Otrivine product range

Otrivine products

Go To

Product range

A range of products to help relieve nasal congestion symptoms

A range of nasal decongestant products developed to relieve the symptoms of cold, allergy and sinusitis.

Call now to order

Pharmacy image

A range of products for professional recommendation.

Recommend Otrivine Nasal Sprays for symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hayfever), sinusitis.

Woman with tissue image

Otrivine Nasal Sprays provide relief from nasal congestion in as little as 2 minutes.

Recommend the Otrivine range to help patients to relieve nasal congestion symptoms

Otrivine Extra Dual Relief

Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml Nasal Spray

A new pharmacy-only medicine, available for you to supply and recommend in pharmacy, without a doctor’s prescription.

Otrivine Congestion Relief

Otrivine Congestion Relief 0.1% Nasal Spray

Provides relief in as little as 2 minutes, lasts up to 10 hours

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis. Combines the instant freshness of menthol with the decongestant power of Otrivine to help relieve even heavy forms of congestion

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Adult Measured Dose Sinusitis

Otrivine Adult Measured Dose Sinusitis Spray

Provides relief in as little as 2 minutes, lasts up to 10 hours

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis.

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Natural with eucalyptus

Otrivine Natural with Eucalyptus Nasal Spray

Contains sea water (hypertonic at 2.2% sea salt concentration), essential oil of Eucalyptus globulus, menthol extracted from Mentha arvensis. Natural relief from nasal congestion due to colds and rhinosinusitis

Suitable for use from 6 years and older

If symptoms persist beyond 7 days for adults and children, consult a healthcare professional

Otrivine Adult Spray 0.1% w/v

Otrivine Adult Spray 0.1% w/v

Provides relief in as little as 2 minutes, lasts up to 10 hours

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis.

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Adult Drops

Otrivine Adult Nasal Drops

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis.

Suitable for use from 12 years and older

Do not use for more than 7 consecutive days.

Otrivine Child Nasal Drops

Otrivine Child Nasal Drops

Relieves symptoms of nasal congestion in connection with the common cold, perennial and allergic rhinitis (including hayfever) sinusitis. Lasts for up to 10 hours.

Suitable for use for 6 - 12 years

Do not use for more than 5 consecutive days.

Otrivine Range Product Information

  • Product information – Otrivine Extra Dual Relief

    Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution. (0.5 mg/ml xylometazoline hydrochloride and 0.6 mg/ml ipratropium bromide).

    Indications: Symptomatic treatment of nasal congestion and rhinorrhea in connection with common colds.

    Dosage: 1 puff in each nostril, up to 3 times daily, with at least 6 hours between doses. Not for use longer than 7 days.

    Contraindications: Children and adolescents under 18 years. Known hypersensitivity to xylometazoline hydrochloride or ipratropium bromide or any excipients or hypersensitivity to atropine or similar substances. Patients with glaucoma or rhinitis sicca or following trans-sphenoidal hypophysectomy or surgery exposing the dura mater.

    Warnings and precautions: Use with caution in people with: hypertension, cardiovascular disease, hyperthyroidism, diabetes mellitus, prostatic hypertrophy, bladder stenosis, pheochromocytoma, angle closure glaucoma, epistaxis, paralytic ileus, cystic fibrosis. Caution in people sensitive to adrenergic substances, which may cause sleep disturbances, dizziness, tremor, cardiac arrythmias or elevated blood pressure. Hypersensitivity reactions may occur. Do not use for more than 7 days. Use during pregnancy or breastfeeding only if clearly necessary. Avoid contact with eyes.

    Side effects: See SPC for full details. Hypersensitivity reactions (including angioedema, urticaria and bronchospasm). Localised irritation in the nose and throat, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, systemic allergic reactions, insomnia, fatigue, urine retention and transient visual disturbances.

    Price: £6.66 (ex. VAT)

    Legal Status: P. Licence Number: PL 44673/0153.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: March 2019

  • Product Information – Otrivine Congestion Relief

    Otrivine Congestion Relief 0.1% Nasal Spray. (1 mg/ml of xylometazoline hydrochloride and 0.14 mg of xylometazoline hydrochloride).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults and adolescents over 12 years of age: 1 spray into each nostril, 1 to 3 times daily as needed. Do not exceed 3 applications daily into each nostril.

    Contraindications: Hypersensitivity to the active substance or to any of the excipients. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater.

    Warnings and precautions: Caution must be used in patients showing a strong reaction to adrenergic substances, which may cause signs of insomnia, dizziness, tremor, cardiac arrhythmias or elevated blood pressure. Should not be used for more than seven consecutive days. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism, narrow angle glaucoma or diabetes mellitus. Do not exceed the stated dose. If you are pregnant or taking other medicines or are under a doctor's care consult your doctor before using Otrivine. Not to be used for infants or children under 12 years. Do not use if you have had recent neurosurgery. Consult your doctor before using Otrivine if you have heart or circulatory disease. Some patients who have sensitive nasal passages may feel some local discomfort when applying nasal drops. Other side effects such as palpitations, nausea and headache are very rare. This medicine contains polyoxyl hydrogenated castor oil which may cause skin reactions.

    Side effects: See SPC for full details. Hypersensitivity reactions (including angioedema, rash, pruritus). Localised irritation in the nose and throat, nausea, headache and dryness or discomfort of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, transient visual disturbances.

    Price: £4.08 (ex. VAT)

    Legal Status: P. Licence Number: PL 44673/0151.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: September 2019

  • Product Information – Otrivine Adult Measured Dose Sinusitis

    Otrivine Adult Measured Dose Sinusitis Spray / Otrivine Adult Metered Dose, 0.1% Nasal Spray / Otrivine Allergy Relief, 0.1% Nasal Spray. (0.1% w/v Xylometazoline Hydrochloride).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults and elderly: One application in each nostril 1 to 3 times daily. Not suitable for children under 12 years.

    Contraindications: Known hypersensitivity to xylometazoline. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater.

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia and dizziness. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism, narrow angle glaucoma or diabetes mellitus. If you are pregnant or taking other medicines or are under a doctor's care, consult your doctor before using Otrivine. Not to be used for infants or children under 12 years. Do not use if you have had recent neurosurgery. Consult your doctor before using Otrivine if you have heart or circulatory disease. Some patients who have sensitive nasal passages may feel some local discomfort when applying the product. Other side effects such as palpitations, nausea and headache are very rare. Side effects: A burning sensation in the nose and throat, local irritation, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects have occurred, and this should be kept in mind when giving Otrivine to people with cardiovascular disease. In isolated cases, systemic allergic reactions and transient visual disturbances.

    Price: £3.49 (ex. VAT)

    Legal Status: P.

    Licence Number: PL 44673/0184.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: September 2019

  • Product Information – Otrivine Adult Spray 0.1%

    Otrivine Adult Nasal Spray. (Xylometazoline Hydrochloride 0.1% w/v).

    Indications: For the treatment of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults, children over 12 years and the elderly: One application in each nostril 2 or 3 times daily.

    Contraindications: Known hypersensitivity to Otrivine. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater.

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia and dizziness. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism, narrow angle glaucoma or diabetes mellitus. Do not use if you are sensitive to any of the ingredients of Otrivine. Do not use if you have had recent neurosurgery. Consult your doctor before using Otrivine if you have heart or circulatory disease. Some patients who have sensitive nasal passages may feel some local discomfort when applying the product. Other side effects such as palpitations, nausea and headache are very rare. Use during pregnancy or breastfeeding only if clearly necessary.

    Side effects: A burning sensation in the nose and throat, local irritation, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects have occurred. In isolated cases, systemic allergic reactions and transient visual disturbances.

    Price: £2.91 (ex. VAT)

    Legal Status: P.

    Licence Number: PL 44673/0149.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: September 2019

  • Product Information – Otrivine Adult Nasal Drops

    Otrivine Adult Nasal Drops. (Xylometazoline Hydrochloride 0.1% w/v).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults and elderly (all indications): 2 or 3 drops in each nostril 2 or 3 times daily. The drops are suitable for children over 12 years of age.

    Contraindications: Known hypersensitivity to Otrivine. Patients following trans-sphenoidal hypophysectomy or surgery exposing the dura mater.

    Warnings and precautions: Patients are advised not to take decongestants for more than seven consecutive days, if symptoms persist, consult your doctor. Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia and dizziness. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism, narrow angle glaucoma or diabetes mellitus. If you are pregnant or taking other medicines or are under a doctor's care, consult your doctor before using Otrivine. Do not use if you are sensitive to any of the ingredients of Otrivine. Consult your doctor before using Otrivine if you have heart or circulatory disease. Some patients who have sensitive nasal passages may feel some local discomfort when applying the product. Other side effects such as palpitations, nausea and headache are very rare.

    Side effects: A burning sensation in the nose and throat, local irritation, nausea, headache and dryness of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, systemic allergic reactions and transient visual disturbances.

    Price: £2.91 (ex. VAT)

    Legal Status: P.

    Licence Number: PL 44673/0148.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: September 2019

  • Product Information – Otrivine Child Nasal Drops

    Otrivine Child Nasal Drops. (Xylometazoline Hydrochloride 0.05% w/v).

    Indications: For the relief of nasal congestion associated with the common cold, perennial, allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Children between 6 and 12 years (all indications): 1 or 2 drops, in each nostril 1 or 2 times daily. Not to be used for more than 5 days without the advice of a doctor.

    Contraindications: Known hypersensitivity to Otrivine or any of the excipients. Concomitant use of other sympathomimetic decongestants. Patients with cardiovascular disease including hypertension, diabetes mellitus, phaeochromocytoma, hyperthyroidism, closed angle glaucoma or following trans-sphenoidal hypophysectomy or nasal surgery exposing the dura mater. Contraindicated in patients using monoamine oxidase inhibitors and beta-blockers or have inflammation of the skin and/or mucosa of the nasal vestibule. Not to be used in children under the age of 6 years.

    Warnings and precautions: Caution must be used in patients showing a strong reaction to sympathomimetic agents which may cause signs of insomnia and dizziness. Do not exceed the stated dose or take with any other cough and cold medicine. Some patients who have sensitive nasal passages may feel some local discomfort when applying nasal drops. Other side effects such as palpitations, nausea and headache are very rare. Occasionally small children may show restlessness or sleep disturbance when Otrivine is used. If this occurs Otrivine should be stopped. Expectant mothers should consult their doctors before using Otrivine for themselves.

    Side effects: See SPC for full details. Burning sensation in the nose and throat, local irritation, nausea, headache, and dryness of the nasal mucosa. Systemic cardiovascular effects should be kept in mind in those with cardiovascular disease. In isolated cases, systemic allergic reactions and transient visual disturbances.

    Price: £2.54 (ex. VAT)

    Legal Status: P.

    Licence Number: PL 44673/0147.

    Licence Holder: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, UK.

    Date of revision: September 2019

Help your patients to manage their nasal congestion with Otrivine

Otrivine logo

Otrivine Extra Dual Relief

Find out how Otrivine Extra Dual Relief can help your customers and patients

FIND OUT MORE

Learning lab icon

Learning Lab

Access educational resources to build your knowledge and skills.

Access resources

Products icon

Orders

Contact us today to order products for your pharmacy

Order now